Laurence Harewood

Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence

Niall M. Corcoran, Matthew Hong, Rowan G. Casey et al. · British Journal of Urology · 2011 · 130 citations

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

Mitchell G. Lawrence, Daisuke Obinata, Shahneen Sandhu et al. · European Urology · 2018 · 117 citations · Full text

Ribosome-directed Therapy, Urology, Oncology +8

Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status

Renea A. Taylor, Roxanne Toivanen, Mark Frydenberg et al. · Stem Cells · 2012 · 90 citations · Full text

Embryonic Stem Cell, Lineage Plasticity, Developmental Biology +13

The ability of prostate‐specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume

Niall M. Corcoran, Rowan G. Casey, Matthew Hong et al. · British Journal of Urology · 2011 · 88 citations

Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours

Niall M. Corcoran, Christopher M. Hovens, Matthew Hong et al. · British Journal of Urology · 2011 · 75 citations